<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="ibmpfd" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">ibmpfd</book-part-id>
      <title-group>
        <title>Inclusion Body Myopathy with Paget Disease of Bone and/or Frontotemporal Dementia</title>
        <alt-title alt-title-type="alt-title">Synonyms: Inclusion Body Myopathy with Early-Onset Paget Disease of Bone and/or Frontotemporal Dementia, IBMPFD</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kimonis</surname>
            <given-names>Virginia</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Chief, Division of Genetics and Metabolism <break/>Professor of Pediatrics <break/>University of California Irvine Medical Center <break/>Orange, California</aff>
          <email>vkimonis@uci.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Donkervoort</surname>
            <given-names>Sandra</given-names>
          </name>
          <degrees>MS, CGC</degrees>
          <aff>Neuromuscular and Neurogenetic Disorders of Childhood Section, Neurogenetics Branch<break/>National Institute of Neurological Disorders and Stroke<break/>National Institutes of Health<break/>Bethesda, Maryland</aff>
          <email>donkervoorts@mail.nih.gov</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Watts</surname>
            <given-names>Giles</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>School of Medicine, Health Policy and Practice<break/>Biomedical Research Centre<break/>University of East Anglia<break/>Norwich, Norfolk, United Kingdom</aff>
          <email>giles.watts@uea.ac.uk.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>25</day>
          <month>5</month>
          <year>2007</year>
        </date>
        <date date-type="updated">
          <day>28</day>
          <month>7</month>
          <year>2011</year>
        </date>
        <date date-type="revised">
          <day>19</day>
          <month>5</month>
          <year>2009</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="image" document-type="chapter">IMAGe Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="i-p" document-type="chapter">Incontinentia Pigmenti</related-object>
      <abstract id="ibmpfd.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Inclusion body myopathy associated with Paget disease of bone (PDB) and/or frontotemporal dementia (IBMPFD) is characterized by adult-onset proximal and distal muscle weakness (clinically resembling a limb-girdle muscular dystrophy syndrome), early-onset PDB, and premature frontotemporal dementia (FTD). Muscle weakness progresses to involve other limb and respiratory muscles. Cardiac failure and cardiomyopathy have been observed in later stages. PDB involves focal areas of increased bone turnover that typically lead to spine and/or hip pain and localized enlargement and deformity of the long bones; pathologic fractures occur on occasion. Early stages of FTD are characterized by dysnomia, dyscalculia, comprehension deficits, paraphasic errors, and relative preservation of memory, and later stages by inability to speak, auditory comprehension deficits for even one-step commands, alexia, and agraphia. Mean age at diagnosis for muscle disease and PDB is 42 years; for FTD, 55 years.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>In IBMPFD, the diagnosis of muscle disease is based on serum CK concentration, electromyogram (EMG), and skeletal muscle histology; the diagnosis of PDB is based on serum alkaline phosphatase (ALP) concentration, urine concentrations of pyridinoline (PYD) and deoxypyridinoline (DPD), and skeletal radiographs or radionuclide scan; and the diagnosis of FTD is based on on comprehensive neuropsychological assessment. <italic toggle="yes">VCP</italic> is the only gene in which mutation is known to cause IBMPFD.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Weight control to avoid obesity; physical therapy and stretching exercises to promote mobility and prevent contractures; mechanical aids (canes, walkers, orthotics, wheelchairs) for ambulation/mobility; surgical intervention for foot deformity and scoliosis; respiratory aids when indicated; social and emotional support; assisted living arrangements for muscle weakness and/or dementia; bisphosphonates to relieve pain and disability from PDB.</p>
          <p><italic toggle="yes">Surveillance:</italic> At periodic intervals: echocardiogram and EKG to monitor for evidence of cardiomyopathy; pulmonary function studies; alkaline phosphatase, skeletal x-rays and bone scans to monitor for PDB onset and effectiveness of therapy; assessment of behavior and mental status.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>IBMPFD is inherited in an autosomal dominant manner. An estimated 80% of affected individuals have an affected parent; approximately 20% have the disorder as a result of a <italic toggle="yes">de novo</italic> pathogenic variant. Each child of an individual with IBMPFD has a 50% chance of inheriting the pathogenic variant. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant in the family is known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="ibmpfd.Diagnosis">
        <title>Diagnosis</title>
        <sec id="ibmpfd.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The diagnosis of inclusion body or nonspecific myopathy associated with Paget disease of bone with or without frontotemporal dementia (IBMPFD) is established by the combination of the following:</p>
          <p><bold>Myopathy</bold> that is usually proximal, progressive, and adult-onset:</p>
          <list list-type="bullet">
            <list-item>
              <p>Serum CK concentration is normal to mildly elevated (mean: 195 U/L; range: 40-1145 U/L; normal range: 20-222 U/L).</p>
            </list-item>
            <list-item>
              <p>EMG (electromyogram) shows myopathic changes, and occasionally neuropathic changes including acute and chronic denervation.</p>
            </list-item>
            <list-item>
              <p>Skeletal muscle pathology is typically nonspecific.</p>
              <list list-type="bullet">
                <list-item>
                  <p>Light microscopy of muscle biopsy reveals nonspecific changes: variability in fiber size, type I fiber predominance, and atrophic and hypertrophic fibers. Fibers may contain single or multiple vacuoles. Rimmed vacuoles and cytoplasmic VCP (valosin-containing protein) and ubiquitin-positive inclusions visible in some fibers are characteristic of inclusion body myopathy. The inclusions appear with time and can be observed at a later stage of the disease in some individuals. In advanced cases, severe degenerative muscle changes and fatty replacement of muscle fibers may be noted. Inflammatory cells are absent.</p>
                </list-item>
                <list-item>
                  <p>Electron microscopy may show nonspecific cytoplasmic changes. The characteristic inclusions composed of randomly oriented tubulofilaments, roughly 15-21 nm in diameter, are seen in muscle nuclei and in cytoplasm. In one family, atrophic and vacuolated muscle fibers containing abundant cytoplasmic-paired helical filaments with epitopes of phosphorylated tau, congophilia, abnormal accumulation of &#x003b2;-amyloid precursor protein (&#x003b2;APP) epitopes, and accumulation of apolipoprotein E (ApoE) were observed [<xref ref-type="bibr" rid="ibmpfd.REF.alvarez.1998.a204">Alvarez et al 1998</xref>].</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Paget disease of bone (PDB),</bold> suspected in individuals with spine or hip pain, bony tenderness, reduced height, pathologic fractures, long-bone or cranial-bone deformity, or hearing loss resulting from eighth-nerve compression by calvarial bony overgrowth. The diagnosis of PDB can be established with the following findings:</p>
          <list list-type="bullet">
            <list-item>
              <p>Elevated serum alkaline phosphatase (ALP) concentration (mean: 359 U/L; range: 58-1724 U/L; normal range: 30-130 U/L)</p>
            </list-item>
            <list-item>
              <p>Elevated urine concentrations of pyridinoline (PYD) and deoxypyridinoline (DPD):</p>
              <list list-type="bullet">
                <list-item>
                  <p>Mean PYD: 153 IU/L (normal: 31.1 IU/L)</p>
                </list-item>
                <list-item>
                  <p>Mean DPD: 40 IU/L (normal: 6.8 IU/L)</p>
                </list-item>
              </list>
              <p>Note: The DPD/PYD ratio is not significantly different between affected persons (0.291) and normal controls (0.214).</p>
            </list-item>
            <list-item>
              <p>Bone findings &#x02013; <bold>either</bold> of the following:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Skeletal radiographs reveal diagnostic changes of coarse trabeculation; cortical thickening; and spotty sclerosis in the skull, pelvis, spine, and scapula that later becomes widespread. Radiographic findings of PDB are typically present ten to 15 years before the diagnosis of PDB can be made based on clinical findings.</p>
                </list-item>
                <list-item>
                  <p>Radionuclide scan shows focally increased bony uptake (a more sensitive indicator of PDB than skeletal radiographs).</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Frontotemporal dementia (FTD),</bold> diagnosed by comprehensive neuropsychological assessment that reveals behavioral alteration (e.g., personal/social unawareness, perseveration, disinhibition), early expressive or receptive language dysfunction, and relative preservation of memory, orientation, and praxis [<xref ref-type="bibr" rid="ibmpfd.REF.miller.1997.937">Miller et al 1997</xref>]. Imaging studies reveal atrophy of anterior temporal and frontal lobes.</p>
        </sec>
        <sec id="ibmpfd.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">VCP</italic>, encoding valosin-containing protein (VCP), a member of the AAA-ATPase superfamily, is the only gene in which mutation is known to cause inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD). Note:</p>
          <list list-type="bullet">
            <list-item>
              <p>In the majority of families with IBMPFD that link to 9p, pathogenic variants in <italic toggle="yes">VCP</italic> have been identified.</p>
            </list-item>
            <list-item>
              <p>In families with isolated PDB that link to 9p, <italic toggle="yes">VCP</italic> pathogenic variants have not been identified [<xref ref-type="bibr" rid="ibmpfd.REF.lucas.2006.280">Lucas et al 2006</xref>].</p>
            </list-item>
          </list>
          <p><bold>Evidence for locus heterogeneity.</bold> Several families that meet diagnostic criteria for IBMPFD have not had an identifiable pathogenic variant in <italic toggle="yes">VCP</italic> and have not shown linkage to 9p21.2 [Authors, unpublished data], suggesting genetic heterogeneity for this disorder [<xref ref-type="bibr" rid="ibmpfd.REF.waggoner.2002.187">Waggoner et al 2002</xref>].</p>
          <p>
            <bold>Testing</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Sequence analysis.</bold> A <italic toggle="yes">VCP</italic> pathogenic variant has been identified in all families with IBMPFD that have shown linkage to 9p (see <xref ref-type="table" rid="ibmpfd.T.selected_vcp_pathogenic_variant">Table 2</xref> for specific pathogenic variants identified) [Author, personal observation].</p>
            </list-item>
            <list-item>
              <p><bold>Targeted analysis for pathogenic variants.</bold> Using a panel of the ten known pathogenic variants*, a pathogenic variant was identified in 27/37 (70%) of probands [Author, personal observation].</p>
              <p>* Known pathogenic variants: <xref ref-type="table" rid="ibmpfd.T.selected_vcp_pathogenic_variant">p.Arg93Cys</xref>, <xref ref-type="table" rid="ibmpfd.T.selected_vcp_pathogenic_variant">p.Arg95Gly</xref>, <xref ref-type="table" rid="ibmpfd.T.selected_vcp_pathogenic_variant">p.Arg191Gln</xref>, <xref ref-type="table" rid="ibmpfd.T.selected_vcp_pathogenic_variant">p.Arg155Cys</xref>, <xref ref-type="table" rid="ibmpfd.T.selected_vcp_pathogenic_variant">p.Arg155Pro</xref>, <xref ref-type="table" rid="ibmpfd.T.selected_vcp_pathogenic_variant">p.Arg159His</xref>, <xref ref-type="table" rid="ibmpfd.T.selected_vcp_pathogenic_variant">p.Ala232Glu</xref>, <xref ref-type="table" rid="ibmpfd.T.selected_vcp_pathogenic_variant">p.Leu198Trp</xref>, <xref ref-type="table" rid="ibmpfd.T.selected_vcp_pathogenic_variant">p.Asn387His</xref></p>
            </list-item>
          </list>
          <table-wrap id="ibmpfd.T.summary_of_molecular_genetic_te" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Inclusion Body Myopathy with Paget Disease of Bone and/or Frontotemporal Dementia</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ibmpfd.T.summary_of_molecular_genetic_te_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_ibmpfd.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_ibmpfd.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_ibmpfd.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ibmpfd.T.summary_of_molecular_genetic_te_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">VCP</italic>
                  </td>
                  <td headers="hd_h_ibmpfd.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_ibmpfd.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  <td headers="hd_h_ibmpfd.T.summary_of_molecular_genetic_te_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">~100%&#x000a0;<sup>5</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="ibmpfd.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="ibmpfd" object-id="ibmpfd.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="ibmpfd.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="ibmpfd.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="ibmpfd.TF.1.3">
                <label>3. </label>
                <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
              </fn>
              <fn id="ibmpfd.TF.1.4">
                <label>4. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="ibmpfd.TF.1.5">
                <label>5. </label>
                <p>In families who meet diagnostic criteria for IBMPFD and show linkage to 9p21.1-p12</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="ibmpfd.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a proband.</bold> Evaluation strategy to establish the cause of IBMPFD in an affected person includes the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Clinical evaluation.</bold> A thorough medical history, neurologic history, and physical examination focusing on features associated with IBMPFD. Comprehensive testing should include electrophysiologic testing of muscle; muscle biopsy for histologic examination for rimmed vacuoles and inclusions; laboratory testing for serum creatinine phosphokinase (CK) concentration; serum alkaline phosphatase (ALP) concentration, and urine concentrations of pyridinoline (PYD) and deoxypyridinoline (DPD); skeletal radiographs and bone scan; and, if clinically indicated, neuropsychological testing.</p>
            </list-item>
            <list-item>
              <p><bold>Family history.</bold> A three-generation family history with attention to other relatives with possible IBMPFD. Documentation of relevant findings in family members can be accomplished either through direct examination of those individuals or through review of their medical records including neuroimaging, neuropathology, neurologic examination, and results of molecular genetic testing.</p>
            </list-item>
            <list-item>
              <p><bold>Confirmation of the diagnosis in a proband.</bold> Detection of a pathogenic variant in <italic toggle="yes">VCP</italic> is the only way to confirm the clinical diagnosis of IBMPFD. <italic toggle="yes">VCP</italic> molecular genetic testing should be accompanied by formal genetic counseling.</p>
            </list-item>
          </list>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant in the family.</p>
        </sec>
      </sec>
      <sec id="ibmpfd.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="ibmpfd.Clinical_Description">
          <title>Clinical Description</title>
          <p>Inclusion body myopathy associated with Paget disease of bone (PDB) and/or frontotemporal dementia (IBMPFD) is characterized by adult-onset proximal and distal muscle weakness (clinically resembling a limb-girdle muscular dystrophy syndrome), early-onset PDB in most cases, and premature frontotemporal dementia (FTD).</p>
          <p>The association of inclusion body myopathy and frontotemporal dementia was established by <xref ref-type="bibr" rid="ibmpfd.REF.kovach.2001.458">Kovach et al [2001]</xref> among 49 affected individuals from the original family described by <xref ref-type="bibr" rid="ibmpfd.REF.kimonis.2000.232">Kimonis et al [2000]</xref> and three other unrelated families.</p>
          <p>The phenotype has been expanded based on findings in affected individuals from 27 families from North and South America and Europe who harbor <italic toggle="yes">VCP</italic> pathogenic missense variants [<xref ref-type="bibr" rid="ibmpfd.REF.haubenberger.2005.1304">Haubenberger et al 2005</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.schr_der.2005.457">Schr&#x000f6;der et al 2005</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.guyantmar_chal.2006.644">Guyant-Mar&#x000e9;chal et al 2006</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.h_bbers.2007.381">H&#x000fc;bbers et al 2007</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.kimonis.2008.745">Kimonis et al 2008</xref>].</p>
          <p><xref ref-type="bibr" rid="ibmpfd.REF.kimonis.2008.745">Kimonis et al [2008]</xref> reviewed the clinical variability among 29 individuals from nine families, in whom the diagnosis was confirmed by the presence of a pathogenic variant in <italic toggle="yes">VCP</italic>. In those individuals, diagnoses that had been considered before the diagnosis of IBMPFD was established by molecular genetic testing included the following: <related-object link-type="booklink" source-id="gene" document-id="lgmd-overview" document-type="chapter">limb-girdle muscular dystrophy</related-object> (LGMD) (11 persons); scapuloperoneal muscular dystrophy (SPMD) (8); <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">amyotrophic lateral sclerosis</related-object> (ALS) (3); <related-object link-type="booklink" source-id="gene" document-id="sma" document-type="chapter">spinal muscular atrophy</related-object> (SMA) (2); diabetic neuropathy (2); inclusion body myositis (1); multiple sclerosis (1); polymyositis (1); <related-object link-type="booklink" source-id="gene" document-id="fsh" document-type="chapter">facioscapulohumeral (FSH) muscular dystrophy</related-object> (1); and distal myopathy / <related-object link-type="booklink" source-id="gene" document-id="opmd" document-type="chapter">oculopharyngeal muscular dystrophy</related-object> / <related-object link-type="booklink" source-id="gene" document-id="mfm" document-type="chapter">myofibrillar myopathy</related-object> (1). The remaining individuals were diagnosed with a nonspecific myopathy. Several persons had more than one diagnosis made over the course of their illness.</p>
          <p><bold>Myopathy.</bold> In families studied thus far, 92% of affected individuals had proximal limb-girdle weakness. Diagnosis was at a mean age of 42 years (range: 3-61 years; typically 20s-40s). Muscle weakness is usually proximal, involving the hip and shoulder girdle muscles; however, several individuals have had initial weakness of the distal muscles of the hands and feet. Affected individuals experience difficulty walking upstairs and raising the arms above the shoulders. The gait is typically waddling and the stance lordotic.</p>
          <p>Weakness progresses and other limb and respiratory muscle groups become involved over time. Many affected individuals become wheelchair bound.</p>
          <p>Death typically occurs in the 50s-60s from progressive respiratory and cardiac failure.</p>
          <p><bold>Dilated cardiomyopathy.</bold> In several individuals in the first family originally reported by <xref ref-type="bibr" rid="ibmpfd.REF.kimonis.2000.232">Kimonis et al [2000]</xref> with limb-girdle myopathy and Paget disease of bone, cardiac failure and cardiomyopathy were noted in the later stages of the disease. <xref ref-type="bibr" rid="ibmpfd.REF.h_bbers.2007.381">H&#x000fc;bbers et al [2007]</xref> reported dilated cardiomyopathy in a woman with the common pathogenic variant characterized by ubiquitin-positive cytoplasmic aggregates and nuclear inclusions. See <related-object link-type="booklink" source-id="gene" document-id="dcm-ov" document-type="chapter">Dilated Cardiomyopathy Overview</related-object>.</p>
          <p><bold>Paget disease of bone (PDB).</bold> In families studied thus far, 51% of affected individuals had PDB. Mean age at diagnosis was 42 years (range: 31-61 years). PDB was occasionally asymptomatic, but was diagnosed based on the serum concentration of alkaline phosphatase; therefore, it may be underdiagnosed.</p>
          <p>PDB involves focal areas of increased bone turnover that lead to complications such as bone pain, localized painful enlargement and deformity of the long bones, pathologic fractures (rare), and deafness. PDB typically manifests as spine and/or hip pain.</p>
          <p><bold>Frontotemporal dementia.</bold> FTD is a degenerative condition of the frontal and anterior temporal lobes that differs from the dementia seen in disorders such as Alzheimer disease (see <related-object link-type="booklink" source-id="gene" document-id="alzheimer" document-type="chapter">Alzheimer Disease Overview</related-object>), Pick disease, and Creutzfeldt-Jakob disease (see <related-object link-type="booklink" source-id="gene" document-id="prion" document-type="chapter">Prion Diseases</related-object>). The areas of the brain affected by FTD control reasoning, personality, movement, speech, social graces, and language; memory is preserved.</p>
          <p>Among those studied, features were consistent with frontotemporal dementia. In the early stages, dysnomia, dyscalculia, comprehension deficits, and paraphasic errors were evident. Adjusting for aphasia, episodic memory is minimally impaired in the early stages. Progressive aphasia with inability to speak, auditory comprehension deficits for even one-step commands, alexia, and agraphia are noted.</p>
          <p>In families studied thus far, approximately 30% of affected individuals had frontotemporal dementia. Mean age at diagnosis of dementia was 55 years (range: 42-61 years). Several individuals were in advanced stages of dementia when diagnosed with IBMPFD.</p>
          <p><bold>Amyotrophic lateral sclerosis (ALS).</bold> Published data indicate that up to 10% of individuals with <italic toggle="yes">VCP</italic>-confirmed IBMPFD had a previous diagnosis of ALS [<xref ref-type="bibr" rid="ibmpfd.REF.kimonis.2008.745">Kimonis et al 2008</xref>].</p>
          <p>Recently five unrelated families with autosomal dominant familial amyotrophic lateral sclerosis (ALS) were found to have a pathogenic variant in <italic toggle="yes">VCP</italic> [<xref ref-type="bibr" rid="ibmpfd.REF.johnson.2010.857">Johnson et al 2010</xref>]. These individuals had limb-onset motor neuron findings with unequivocal upper and lower motor signs affecting all four limbs and bulbar musculature that progressed to quadriparesis and disability. Electrophysiologic studies demonstrated widespread changes of ongoing denervation and chronic reinnervation consistent with ALS. Serum concentration of alkaline phosphatase was within normal limits, thereby excluding concomitant Paget disease. The parent of one proband died at age 58 years with dementia, parkinsonism, Paget disease, and upper-limb muscle weakness, findings that strongly suggest IBMPFD. In another individual with a pathogenic variant in <italic toggle="yes">VCP</italic> and diagnosis of ALS, neuropsychological testing performed within one year of symptom onset suggested mild frontal lobe dysfunction.</p>
          <p><xref ref-type="bibr" rid="ibmpfd.REF.kumar.2010.330">Kumar et al [2010]</xref> reported an individual with IBMPFD from an Australian family with a novel <italic toggle="yes">VCP</italic> pathogenic variant (p.Arg155Leu) in whom the clinical findings of muscle wasting, fasciculations, and upper-motor neuron signs on physical examination and neurogenic (rather than myopathic) changes on EMG strongly suggested the diagnosis of ALS. See <related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter">Amyotrophic Lateral Sclerosis Overview</related-object>.</p>
          <p><bold>Other phenotypic features</bold> including hepatic steatosis, cataracts, sensory-motor axonal neuropathy, pyramidal tract dysfunction, sphincter disturbance, and sensorineural hearing loss have been reported [<xref ref-type="bibr" rid="ibmpfd.REF.haubenberger.2005.1304">Haubenberger et al 2005</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.guyantmar_chal.2006.644">Guyant-Mar&#x000e9;chal et al 2006</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.h_bbers.2007.381">H&#x000fc;bbers et al 2007</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.djamshidian.2009.389">Djamshidian et al 2009</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.miller.2009.583">Miller et al 2009</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.kumar.2010.330">Kumar et al 2010</xref>].</p>
          <p><bold>Neuropathology.</bold>
<italic toggle="yes">VCP</italic>-related disease represents a novel class of neurodegenerative diseases called TDP-43 proteinopathies. A systematic analysis of the neuropathologic changes in eight persons with IBMPFD and mutation of <italic toggle="yes">VCP</italic> revealed a novel pattern of ubiquitin pathology characterized by ubiquitin-positive neuronal intranuclear inclusions, dystrophic neuritis, and rare intracytoplasmic inclusions. The ubiquitin pathology was abundant in the neocortex, less robust in limbic and subcortical nuclei, and absent in the dentate gyrus. Only rare inclusions were detected with antibodies to VCP and TDP-43 [<xref ref-type="bibr" rid="ibmpfd.REF.forman.2006.571">Forman et al 2006</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.neumann.2007.152">Neumann et al 2007</xref>]. These findings support the hypothesis that neuropathologic changes associated with <italic toggle="yes">VCP</italic> pathogenic variants result from impairment of ubiquitin-based degradation pathways.</p>
          <p>In a study of ubiquitin and TDP-43 immunohistochemistry on 193 individuals with familial and simplex (i.e., a single occurrence in a family) frontotemporal lobar degeneration (FTLD) with or without motor neuron disease, including five with familial FTD caused by mutation of <italic toggle="yes">VCP,</italic>
<xref ref-type="bibr" rid="ibmpfd.REF.cairns.2007.227">Cairns et al [2007]</xref> determined that TDP-43 is a major component of the pathologic inclusions in familial FTD caused by mutation of <italic toggle="yes">VCP</italic>. Specifically, persons with a pathogenic variant in <italic toggle="yes">VCP</italic> had exclusively type 4 FTLD-U (ubiquitin-positive, tau-negative frontotemporal lobar degeneration) pathology, distinguished by numerous neuronal intranuclear inclusions, infrequent neuronal cytoplasmic inclusions, and dystrophic neurites in neocortical areas with relative sparing of the hippocampus.</p>
          <p><xref ref-type="bibr" rid="ibmpfd.REF.van_der_zee.2009.626">Van der Zee et al [2009]</xref> published autopsy data on three individuals in two Belgian families with <italic toggle="yes">VCP</italic> pathogenic variants; data were consistent with FTLD-TDP type 4 pathology, showing numerous ubiquitin-immunoreactive, intranuclear inclusions, and dystrophic neuritis staining positive for TDP-43 protein.</p>
        </sec>
        <sec id="ibmpfd.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Clinical, radiologic, biochemical, and pathogenic variant data were analyzed in 103 individuals from 14 families:</p>
          <list list-type="bullet">
            <list-item>
              <p>Individuals with the pathogenic variant <xref ref-type="table" rid="ibmpfd.T.selected_vcp_pathogenic_variant">p.Arg155Cys</xref> had an earlier age of onset of IBM (p=0.01) and those with the <xref ref-type="table" rid="ibmpfd.T.selected_vcp_pathogenic_variant">p.Arg155His</xref> variant had a later onset of PDB (p&#x0003c;0.05) compared to the others [<xref ref-type="bibr" rid="ibmpfd.REF.watts.2007.420">Watts et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p>A pathogenic variant in the main catalytic D1 ATPase domain of <italic toggle="yes">VCP</italic> (<xref ref-type="table" rid="ibmpfd.T.selected_vcp_pathogenic_variant">p.Ala232Glu</xref>) essential for hexamer formation was found in a single family with a more aggressive type of disease.</p>
            </list-item>
          </list>
          <p>Because of the range of phenotypes associated with mutation of <italic toggle="yes">VCP</italic>, several studies have looked at modifier genes:</p>
          <list list-type="bullet">
            <list-item>
              <p>From a database of 231 members of 15 families, 174 had <italic toggle="yes">APOE</italic> genotype available for regression analysis. Analysis of the data suggests a potential link between <italic toggle="yes">APOE</italic> e4 genotype and the frontotemporal dementia found in IBMPFD [<xref ref-type="bibr" rid="ibmpfd.REF.mehta.2007.9">Mehta et al 2007</xref>].</p>
            </list-item>
            <list-item>
              <p>No association between frontotemporal dementia and microtubule associated protein tau (<italic toggle="yes">MAPT</italic>) H2 haplotype was observed (p=0.5) [Author, personal observation].</p>
            </list-item>
          </list>
        </sec>
        <sec id="ibmpfd.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance is almost complete; however, it is age related.</p>
          <p><bold>Penetrance by phenotype.</bold> (See <xref ref-type="fig" rid="ibmpfd.F1">Figure 1</xref>.) There is marked intrafamilial and interfamilial variability in severity, age of onset, distribution of weakness, and presence or absence of Paget's disease, myopathy, or cognitive impairment:</p>
          <list list-type="bullet">
            <list-item>
              <p>Presence of all three major manifestations: 12% of affected individuals</p>
            </list-item>
            <list-item>
              <p>Presence of only two major manifestations in any combination: 50% of affected individuals</p>
            </list-item>
            <list-item>
              <p>Each of the three major manifestations as an apparently isolated finding:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Myopathy (IBM): 30%</p>
                </list-item>
                <list-item>
                  <p>Paget disease of bone (PDB): 5%</p>
                </list-item>
                <list-item>
                  <p>Frontotemporal dementia (FTD): 3%</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="ibmpfd.Anticipation">
          <title>Anticipation</title>
          <p>There is no evidence of anticipation in IBMPFD.</p>
        </sec>
        <sec id="ibmpfd.Prevalence">
          <title>Prevalence</title>
          <p>IBMPFD is rare; the true prevalence is unknown. Twenty-six families have been studied by the authors, who believe the disorder to be underdiagnosed. Because the spectrum of disorders associated with mutation of <italic toggle="yes">VCP</italic> is expanding (as indicated by the number of worldwide publications) it is anticipated that the disorder will be increasingly recognized.</p>
        </sec>
      </sec>
      <sec id="ibmpfd.Genetically_Related_Allelic_Disor">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold>Other phenotypes</bold> associated with mutation of <italic toggle="yes">VCP</italic> include isolated:</p>
        <list list-type="bullet">
          <list-item>
            <p>Proximal limb-girdle myopathy</p>
          </list-item>
          <list-item>
            <p>Paget disease of bone</p>
          </list-item>
          <list-item>
            <p>Dementia</p>
          </list-item>
          <list-item>
            <p>Familial amyotrophic lateral sclerosis (ALS). At this point, additional research is necessary to establish whether mutation of <italic toggle="yes">VCP</italic> causes familial ALS without other manifestations and, if so, the frequency of <italic toggle="yes">VCP</italic> mutation in familial ALS.</p>
          </list-item>
        </list>
      </sec>
      <sec id="ibmpfd.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD) includes the following disorders.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="lgmd-overview" document-type="chapter"><bold>Limb-girdle muscular dystrophy</bold></related-object>
<bold>(LGMD).</bold> Because the muscle biopsy is nonspecific in the majority of individuals with IBMPFD, the disorder has been labeled as an LGMD.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="ibm" document-type="chapter"><bold>Inclusion body myopathy type 2</bold></related-object>
<bold>(IBM2).</bold> IBM2 is characterized by adult-onset, slowly progressive distal muscle weakness that begins with gait disturbance and foot drop secondary to anterior tibialis muscle weakness. Weakness eventually includes the hand and thigh muscles, but commonly spares the quadriceps muscles, even in advanced disease. Affected individuals are usually wheelchair bound approximately 20 years after onset. If quadriceps sparing is incomplete, loss of ambulation tends to occur earlier. Muscle histopathology typically shows rimmed vacuoles and characteristic filamentous inclusions. <italic toggle="yes">GNE</italic>, encoding the bifunctional enzyme UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase, is the only gene in which mutation is known to cause IBM2. Inheritance is autosomal recessive [<xref ref-type="bibr" rid="ibmpfd.REF.eisenberg.2001.83">Eisenberg et al 2001</xref>].</p>
        <p><bold>Sporadic inclusion-body myositis (sIBM)</bold> is the most common acquired muscle disease in individuals of European heritage older than age 50 years. Pathologically it is characterized by inflammatory, degenerative, and mitochondrial changes that interact in an as-yet-unknown manner to cause progressive muscle degeneration and weakness. The cause is unknown, but it is thought to involve a complex interplay between environmental factors, genetic susceptibility, and aging [<xref ref-type="bibr" rid="ibmpfd.REF.askanas.2002.525">Askanas &#x00026; Engel 2002</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="fsh" document-type="chapter"><bold>Facioscapulohumeral muscular dystrophy</bold></related-object>
<bold>(FSHD).</bold> FSHD typically presents before age 20 years with weakness of the facial muscles and the stabilizers of the scapula or the dorsiflexors of the foot. Severity is variable. Weakness is slowly progressive and approximately 20% of affected individuals eventually require a wheelchair. Life expectancy is not shortened. Inheritance is autosomal dominant.</p>
        <p><bold>Scapuloperoneal myopathy (SPM)</bold> (also known as scapuloperoneal muscular dystrophy (SPMD) or scapuloperoneal syndrome, myopathic type). Scapuloperoneal syndromes are heterogeneous. They are characterized by weakness in the distribution of the shoulder girdle and peroneal muscles. Scapuloperoneal myopathy can resemble FSHD clinically. The locus for SPMD has been assigned to 12q [<xref ref-type="bibr" rid="ibmpfd.REF.wilhelmsen.1996.507">Wilhelmsen et al 1996</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="als-overview" document-type="chapter"><bold>Amyotrophic lateral sclerosis</bold></related-object>
<bold>(ALS).</bold> Because of asymmetric involvement and association of both distal and proximal muscle groups, individuals with IBMPFD have been misdiagnosed as having ALS. Published data indicate that up to 10% of individuals with <italic toggle="yes">VCP</italic>-confirmed IBMPFD had a previous diagnosis of ALS [<xref ref-type="bibr" rid="ibmpfd.REF.kimonis.2008.745">Kimonis et al 2008</xref>]. Furthermore, recent studies indicate that mutation of <italic toggle="yes">VCP</italic> causes ALS, broadening the phenotype of IBMPFD to include motor neuron degeneration [<xref ref-type="bibr" rid="ibmpfd.REF.johnson.2010.857">Johnson et al 2010</xref>].</p>
        <p><bold>Paget disease of bone (PDB).</bold> Genetic heterogeneity is found [<xref ref-type="bibr" rid="ibmpfd.REF.cody.1997.1117">Cody et al 1997</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.hocking.2002.2735">Hocking et al 2002</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.laurin.2002.1582">Laurin et al 2002</xref>]. Germline pathogenic variants of the gene encoding sequestosome 1 have been implicated in Paget disease of bone. A mutation hot spot (p.Pro392Leu) was identified in the ubiquitin-associated domain (UBA) that accounts for 16% of simplex cases (i.e., a single occurrence in a family) and 46% of familial cases in the French Canadian population.</p>
        <p><bold>Frontotemporal dementia (FTD)</bold> causes a substantial proportion of primary degenerative dementia occurring before age 65 years [<xref ref-type="bibr" rid="ibmpfd.REF.chow.1999.817">Chow et al 1999</xref>]. (See <related-object link-type="booklink" source-id="gene" document-id="ftd-chmp2b" document-type="chapter">Chromosome 3-Linked Frontotemporal Dementia</related-object>, <related-object link-type="booklink" source-id="gene" document-id="ftd-grn" document-type="chapter"><italic toggle="yes">GRN</italic>-Related Frontotemporal Dementia</related-object>.)</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="ftdp-17" document-type="chapter"><bold>Frontotemporal dementia with parkinsonism-17</bold></related-object>
<bold>(FTDP-17)</bold> is a presenile dementia affecting the frontal and temporal cortex and some subcortical nuclei. Clinical presentation is variable. Individuals may present with slowly progressive behavioral changes, language disturbances, and/or extrapyramidal signs. Some present with rigidity, bradykinesia, supranuclear palsy, and saccadic eye movement disorders. Symptoms usually start between ages 40 and 60 years, but may occur earlier or later. Disease duration is usually between five and ten years, but occasionally may be up to 20 to 30 years. The disease progresses over a few years into a profound dementia with mutism. <italic toggle="yes">MAPT,</italic> encoding microtubule-associated protein tau, is the only gene in which mutation is known to cause FTDP-17. Inheritance is autosomal dominant [<xref ref-type="bibr" rid="ibmpfd.REF.hutton.1998.702">Hutton et al 1998</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="alzheimer" document-type="chapter"><bold>Alzheimer disease</bold></related-object><bold>.</bold> Imaging studies in IBMPFD reveal atrophy of anterior temporal and frontal lobes. By contrast, more widespread atrophy or perfusion deficits, for example involving parietal lobes, are more compatible with Alzheimer disease.</p>
        <p>
          <bold>Other disorders</bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p>Autosomal dominant limb-girdle myopathy and bone fragility, associated with progressive myopathy of a limb-girdle distribution, bone fragility, poor healing of long bones, premature graying with thin hair, thin skin, hernias, and clotting disorders that may resemble IBMPFD, has been described in a single family [<xref ref-type="bibr" rid="ibmpfd.REF.mehta.2006.322">Mehta et al 2006</xref>]. Skeletal radiographs demonstrate coarse trabeculation, patchy sclerosis, cortical thickening, and narrowing of medullary cavities. A genome-wide scan mapped the disorder to chromosome 9p21-p22, the region in which diaphyseal medullary stenosis with malignant fibrous histiocytoma (DMS-MFH) also maps, suggesting possible allelic heterogeneity [<xref ref-type="bibr" rid="ibmpfd.REF.watts.2005.508">Watts et al 2005</xref>].</p>
          </list-item>
          <list-item>
            <p><xref ref-type="bibr" rid="ibmpfd.REF.waggoner.2002.187">Waggoner et al [2002]</xref> reported a ten-member family with autosomal dominant PDB and a scapuloperoneal type of muscular dystrophy. Molecular analyses excluded all known loci for Paget disease of bone, scapuloperoneal muscular dystrophy (SPMD), facioscapulohumeral muscular dystrophy (FSHD), amyotrophic lateral sclerosis (ALS), <related-object link-type="booklink" source-id="gene" document-id="bethlem" document-type="chapter">Bethlem myopathy</related-object>, two forms of autosomal dominant limb-girdle muscular dystrophy (LGMD), and the critical region for LGMD or HIBM/PDB on chromosome 9p21.1-q12. A genome-wide search identified linkage to chromosome 16q 22.3-q24.1 [<xref ref-type="bibr" rid="ibmpfd.REF.watts.2007.420">Watts et al 2007</xref>], a locus known to contain a quantitative trait locus (QTL) [<xref ref-type="bibr" rid="ibmpfd.REF.ralston.2005.943">Ralston et al 2005</xref>].</p>
          </list-item>
          <list-item>
            <p>Nasu Hakola disease (also known as <related-object link-type="booklink" source-id="gene" document-id="plosl" document-type="chapter">polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy</related-object>, or PLOSL) is a presenile dementia associated with loss of myelin, basal ganglia calcification, and bone cysts. It is caused by recessively inherited pathogenic variants in the two genes <italic toggle="yes">TREM2</italic> and <italic toggle="yes">DAP12</italic>, which encode subunits of a cell membrane-associated receptor complex [<xref ref-type="bibr" rid="ibmpfd.REF.paloneva.2002.656">Paloneva et al 2002</xref>].</p>
          </list-item>
        </list>
      </sec>
      <sec id="ibmpfd.Management">
        <title>Management</title>
        <sec id="ibmpfd.Evaluations_Following_Initial_Dia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Assessment of muscle strength, muscle wasting and tendon reflexes. EMG and/or muscle biopsy may be necessary.</p>
            </list-item>
            <list-item>
              <p>Baseline pulmonary function studies</p>
            </list-item>
            <list-item>
              <p>Cardiac evaluation by echocardiogram and ECG</p>
            </list-item>
            <list-item>
              <p>Blood alkaline phosphatase, urine pyridinoline studies and, if indicated, skeletal x-ray or bone scan studies to evaluate distribution and severity of Paget disease of the bone</p>
            </list-item>
            <list-item>
              <p>Baseline neuropsychological studies of behavior and mental status</p>
            </list-item>
          </list>
        </sec>
        <sec id="ibmpfd.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Individuals benefit from care by a multidisciplinary team that includes: a neurologist, endocrinologist with expertise in Paget disease, specially trained nurses, pulmonologist, speech therapist, physical therapist, occupational therapist, respiratory therapist, nutritionist, psychologist, social worker, and geneticist/genetic counselor.</p>
          <p><bold>Myopathy.</bold> Management should be tailored to the individual. A general approach to appropriate management can prolong survival and improve quality of life. This general approach is based on the typical progression and complications of individuals with <related-object link-type="booklink" source-id="gene" document-id="lgmd-overview" document-type="chapter">LGMD</related-object> as described by <xref ref-type="bibr" rid="ibmpfd.REF.mcdonald.1995.s117">McDonald et al [1995]</xref> and <xref ref-type="bibr" rid="ibmpfd.REF.bushby.1999.1875">Bushby [1999]</xref>.</p>
          <list list-type="bullet">
            <list-item>
              <p>Weight control to avoid obesity</p>
            </list-item>
            <list-item>
              <p>Physical therapy and stretching exercises to promote mobility and prevent contractures</p>
            </list-item>
            <list-item>
              <p>Occupational therapy and use of mechanical aids such as canes, walkers, orthotics, and wheelchairs as needed for ambulation and mobility</p>
            </list-item>
            <list-item>
              <p>Surgical intervention as needed for orthopedic complications such as foot deformity and scoliosis</p>
            </list-item>
            <list-item>
              <p>Use of respiratory aids when indicated</p>
            </list-item>
            <list-item>
              <p>Social and emotional support and stimulation to maximize a sense of social involvement and productivity and to reduce the sense of social isolation common in individuals with these disorders [<xref ref-type="bibr" rid="ibmpfd.REF.eggers.1998.4">Eggers &#x00026; Zatz 1998</xref>]</p>
            </list-item>
            <list-item>
              <p>Assisted living arrangements as necessitated by muscle weakness and/or dementia</p>
            </list-item>
          </list>
          <p><bold>Paget disease of bone.</bold> Treatment with the following potent bisphosphonates can reduce the alkaline phosphatase concentration and relieve pain and disability:</p>
          <list list-type="bullet">
            <list-item>
              <p>Actonel<sup>&#x000ae;</sup>/risedronate</p>
            </list-item>
            <list-item>
              <p>Fosamax<sup>&#x000ae;</sup>/alendronate</p>
            </list-item>
            <list-item>
              <p>Aredia<sup>&#x000ae;</sup>/pamidronate</p>
            </list-item>
          </list>
        </sec>
        <sec id="ibmpfd.Surveillance">
          <title>Surveillance</title>
          <p>At periodic intervals:</p>
          <list list-type="bullet">
            <list-item>
              <p>Echocardiogram and EKG to monitor for evidence of cardiomyopathy</p>
            </list-item>
            <list-item>
              <p>Pulmonary function studies</p>
            </list-item>
            <list-item>
              <p>Alkaline phosphatase, skeletal x-rays, and bone scans for monitoring of the PDB if symptomatic and for monitoring of therapy</p>
            </list-item>
            <list-item>
              <p>Monitoring of behavior and mental status</p>
            </list-item>
          </list>
        </sec>
        <sec id="ibmpfd.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Individuals and their families should be educated about safety precautions and environmental modification in the home and at work.</p>
        </sec>
        <sec id="ibmpfd.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="ibmpfd.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="ibmpfd.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="ibmpfd.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="ibmpfd.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="ibmpfd.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Approximately 80% of individuals diagnosed with IBMPFD have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with IBMPFD may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is estimated to be 20% or greater.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include clinical evaluation by a neurologist familiar with myopathic disorders in addition to laboratory evaluation of creatine phosphokinase and alkaline phosphatase concentrations. If the <italic toggle="yes">VCP</italic> pathogenic variant has been identified in the proband, molecular genetic testing of the parents is possible.</p>
            </list-item>
          </list>
          <p>Note: Approximately 80% of individuals diagnosed with IBMPFD have an affected parent; however, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with IBMPFD has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents. If a parent is affected, his or her family members are at risk.</p>
        </sec>
        <sec id="ibmpfd.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Testing of at-risk asymptomatic adults.</bold> Presymptomatic testing for <italic toggle="yes">VCP</italic> pathogenic variants is possible. Because of the individualized nature of predictive testing, consultation with a genetic counselor or clinical geneticist prior to and following testing is recommended. A testing protocol similar to that used for other genetic disorders (e.g., breast cancer, <related-object link-type="booklink" source-id="gene" document-id="huntington" document-type="chapter">Huntington disease</related-object>, familial Alzheimer disease) has been developed [Kimonis et al, submitted].</p>
          <p><bold>Testing of asymptomatic individuals younger than age 18 years</bold> who are at risk for adult-onset disorders is not considered appropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</p>
          <p>See also the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">position statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
          <p>Individuals younger than age 18 years who are symptomatic usually benefit from having a specific diagnosis established.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has clinical evidence of the disorder, it is likely that mutation occurred <italic toggle="yes">de novo</italic> in the proband. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="ibmpfd.Prenatal_Testing_and_Preimplantat">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">VCP</italic> pathogenic variant has been identified in an affected family member, prenatal diagnosis for a pregnancy at increased risk and preimplantation genetic diagnosis for IBMPFD are possible.</p>
          <p>Requests for prenatal testing for adult-onset conditions such as IBMPFD are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="ibmpfd.Resources">
        <title>Resources</title>
      </sec>
      <sec id="ibmpfd.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">VCP</italic> has 17 exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="ibmpfd" object-id="ibmpfd.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Pathogenic variants identified in the 39 families reported to date are summarized in <xref ref-type="table" rid="ibmpfd.T.selected_vcp_pathogenic_variant">Table 2</xref> and <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="ibmpfd-Table3.pdf" content-type="local-data">Table 3</inline-supplementary-material> (pdf).</p>
        <table-wrap id="ibmpfd.T.selected_vcp_pathogenic_variant" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Selected <italic toggle="yes">VCP</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">c.277C&#x0003e;T</td>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">p.Arg93Cys</td>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_3" rowspan="9" valign="middle" align="left" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_007126.3">NM_007126.3</ext-link>
<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_009057.1">NP_009057.1</ext-link></td>
              </tr>
              <tr>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">c.283C&#x0003e;G</td>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">p.Arg95Gly</td>
              </tr>
              <tr>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">c.463C&#x0003e;T</td>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">p.Arg155Cys</td>
              </tr>
              <tr>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">c.464G&#x0003e;A</td>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">p.Arg155His</td>
              </tr>
              <tr>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">c.464G&#x0003e;C</td>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">p.Arg155Pro</td>
              </tr>
              <tr>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">c.476G&#x0003e;A</td>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">p.Arg159His</td>
              </tr>
              <tr>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">c.572G&#x0003e;A</td>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">p.Arg191Gln</td>
              </tr>
              <tr>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">c.593T&#x0003e;G</td>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">p.Leu198Trp</td>
              </tr>
              <tr>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">c.695C&#x0003e;A</td>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">p.Ala232Glu</td>
              </tr>
              <tr>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">c.1159A&#x0003e;C</td>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">p.Asn387His</td>
                <td headers="hd_h_ibmpfd.T.selected_vcp_pathogenic_variant_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The 97-kd transitional endoplasmic reticulum ATPase (also known as the valosin-containing protein) is a member of the type II AAA ATPases (ATPases associated with a variety of activities), characterized by the presence of two conserved ATPase domains, also called AAA domains. Similar to other AAA proteins, it is an enzymatic machine catalyzing ATP hydrolysis to generate energy and using the energy to perform mechanical work in cells. Transitional endoplasmic reticulum ATPase is involved in an unusually wide variety of functions and is associated with distinct and crucial cell protein pathways, namely cell cycle control homotypic membrane fusion, nuclear envelope reconstruction, postmitotic organelle reassembly, and ubiquitin-dependent protein degradation [<xref ref-type="bibr" rid="ibmpfd.REF.rabouille.1998.603">Rabouille et al 1998</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.hetzer.2001.1086">Hetzer et al 2001</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.rabinovich.2002.626">Rabinovich et al 2002</xref>]. Transitional endoplasmic reticulum ATPase forms a homohexamer and binds to several different adapter proteins, enabling it to target specific substrates for degradation [<xref ref-type="bibr" rid="ibmpfd.REF.kondo.1997.75">Kondo et al 1997</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.meyer.2000.2181">Meyer et al 2000</xref>]. Transitional endoplasmic reticulum ATPase plays a critical role in the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway during the "quality control process" that selectively eliminates aberrant proteins in the secretory pathway [<xref ref-type="bibr" rid="ibmpfd.REF.jarosch.2002.530">Jarosch et al 2002</xref>]. This pathway also targets destruction of protein substrates dislocated from the ER to the cytosol, where ubiquitination and degradation occur by the 26S proteasome [<xref ref-type="bibr" rid="ibmpfd.REF.dai.2001.740">Dai &#x00026; Li 2001</xref>].</p>
        <p><bold>Abnormal gene product.</bold>
<italic toggle="yes">VCP</italic> pathogenic variants in families with IBMPFD cluster in the N-terminal CDC48 domain, involved in ubiquitin binding [<xref ref-type="bibr" rid="ibmpfd.REF.dai.2001.740">Dai &#x00026; Li 2001</xref>, <xref ref-type="bibr" rid="ibmpfd.REF.rape.2001.667">Rape et al 2001</xref>]. This highly structured domain forms two distinct regions &#x02014; the double &#x003c8; barrel (amino acids 25-106) and the four-stranded &#x003b2; barrel (amino acids 112-186) &#x02014; connected by a short linker region (amino acids 107-111). Transitional endoplasmic reticulum ATPase forms a homohexamer in which the D1/D2 domains bind in a head-to-tail ring [<xref ref-type="bibr" rid="ibmpfd.REF.zhang.2000.1473">Zhang et al 2000</xref>], allowing the N-terminal domain to undergo conformational changes without affecting the stability of the homohexamer ring structure.</p>
        <p>IBMPFD-causing missense variants in <italic toggle="yes">VCP</italic> encode amino acids that disrupt either the double &#x003c8; barrel (p.Arg93Cys, p.Arg95Gly/Cys), the four-stranded &#x003b2; barrel (p.Arg155Cys/His/Pro, p.Arg159His), or the flexible linker (p.Arg191Gln). Hence, the affected ubiquitin-binding domain may possibly impair N-terminal domain binding of specific partner proteins. Most of the mutated residues are adjacent and potentially interact with each other (p.Arg155-p.Asn387, p.Arg159-p.Ala232 and p.Arg191-p.Leu198), suggesting that these residues may have a similar and specific function within the homohexamer. <xref ref-type="bibr" rid="ibmpfd.REF.halawani.2009.4484">Halawani et al [2009]</xref> revealed that proteins encoded by <italic toggle="yes">VCP</italic> pathogenic variants p.Arg155Prp and p.Ala232Glu form hexameric ring-shaped structures, exhibiting an approximately threefold increase in ATPase activity and displayed increased sensitivity to heat-induced upregulation of ATPase activity compared to wild type. Protein fluorescence analysis showed conformational differences in the D2 rings and increased the proteolytic susceptibility of both proteins from the <italic toggle="yes">VCP</italic> pathogenic variants. It was suggested that proteins encoded by <italic toggle="yes">VCP</italic> pathogenic variants p.Arg155Pro and p.Ala232Glu possess structural defects that may compromise the mechanism of VCP activity within large multiprotein complexes.</p>
        <p>Growing evidence implicates transitional endoplasmic reticulum ATPase in neuronal degeneration. Several in vitro studies, using neuronally differentiated mammalian cell lines, show that pathogenic variants encoding the D2 domain of <italic toggle="yes">VCP</italic> are associated with polyubiquitinated proteins that accumulate in nuclear and membrane cellular fractions and induce cytoplasmic vacuoles. Transitional endoplasmic reticulum ATPase also binds to expanded polyglutamine (poly-Q) protein aggregates. The poly-Q binding domain of human transitional endoplasmic reticulum ATPase maps to amino acid residues 142-200, encompassing a region of the N domain and linker (N domain to D1) domain.</p>
        <p>Recently transitional endoplasmic reticulum ATPase has been associated with the degradation of aggregate-prone proteins, a process principally mediated by autophagy. Proteins encoded by mutated <italic toggle="yes">VCP</italic> were shown to lead to accumulation of autophagic structures in patient and transgenic animal tissue, likely due to a defect in transitional endoplasmic reticulum ATPase-mediated autophagosome maturation [<xref ref-type="bibr" rid="ibmpfd.REF.ju.2010.r38">Ju &#x00026; Weihl 2010</xref>].</p>
        <p><inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="ibmpfd-animal_models.pdf" content-type="local-data"><bold>Animal models for IBMPFD</bold></inline-supplementary-material> (pdf)</p>
      </sec>
      <sec id="ibmpfd.References">
        <title>References</title>
        <sec id="ibmpfd.Published_GuidelinesConsensus_Sta">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="ibmpfd.Published_GuidelinesConsensus_Sta.reflist0">
            <ref id="ibmpfd.REF1">
              <mixed-citation publication-type="web">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. 2013. Accessed 1-23-17.</mixed-citation>
            </ref>
            <ref id="ibmpfd.REF2">
              <mixed-citation publication-type="web">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 1-23-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="ibmpfd.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="ibmpfd.Literature_Cited.reflist0">
            <ref id="ibmpfd.REF.alvarez.1998.a204">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alvarez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simmons</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Askanas</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>New autosomal dominant inclusion body myopathy (AD-IBM) with many congophilic muscle nuclei that contain paired-helical filaments (PHFs) composed of phosphorylated tau.</article-title>
                <source>Neurology</source>
                <volume>50</volume>
                <fpage>A204</fpage>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.askanas.2002.525">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Askanas</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engel</surname>
                    <given-names>WK</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms.</article-title>
                <source>Curr Opin Neurol</source>
                <volume>15</volume>
                <fpage>525</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">12351995</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.bushby.1999.1875">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>KM</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms.</article-title>
                <source>Hum Mol Genet</source>
                <volume>8</volume>
                <fpage>1875</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">10469840</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.cairns.2007.227">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cairns</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bigio</surname>
                    <given-names>EH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holm</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Troost</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hatanpaa</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foong</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>CL</given-names>
                    <suffix>3rd</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kretzschmar</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor-Reinwald</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paulsmeyer</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strider</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gitcho</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goate</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mishra</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwong</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stieber</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forman</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trojanowski</surname>
                    <given-names>JQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackenzie</surname>
                    <given-names>IR</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions.</article-title>
                <source>Am J Pathol.</source>
                <volume>171</volume>
                <fpage>227</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">17591968</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.chow.1999.817">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chow</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>VN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geschwind</surname>
                    <given-names>DH</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Inheritance of frontotemporal dementia.</article-title>
                <source>Arch Neurol</source>
                <volume>56</volume>
                <fpage>817</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">10404983</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.cody.1997.1117">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cody</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singer</surname>
                    <given-names>FR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roodman</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otterund</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leppert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leach</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Genetic linkage of Paget disease of the bone to chromosome 18q.</article-title>
                <source>Am J Hum Genet</source>
                <volume>61</volume>
                <fpage>1117</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">9345096</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.dai.2001.740">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dai</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>CC</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation.</article-title>
                <source>Nat Cell Biol</source>
                <volume>3</volume>
                <fpage>740</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11483959</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.djamshidian.2009.389">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Djamshidian</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haubenberger</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stogmann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auff</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>A novel mutation in the VCP gene (G157R) in a German family with inclusion-body myopathy with Paget disease of bone and frontotemporal dementia.</article-title>
                <source>Muscle Nerve.</source>
                <volume>39</volume>
                <fpage>389</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">19208399</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.eggers.1998.4">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eggers</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zatz</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Social adjustment in adult males affected with progressive muscular dystrophy.</article-title>
                <source>Am J Med Genet</source>
                <volume>81</volume>
                <fpage>4</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">9514580</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.eisenberg.2001.83">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eisenberg</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avidan</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potikha</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hochner</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olender</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barash</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shemesh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadeh</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grabov-Nardini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shmilevich</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karpati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bradley</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumbach</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lancet</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asher</surname>
                    <given-names>EB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beckmann</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Argov</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitrani-Rosenbaum</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy.</article-title>
                <source>Nat Genet</source>
                <volume>29</volume>
                <fpage>83</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">11528398</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.forman.2006.571">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Forman</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackenzie</surname>
                    <given-names>IR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cairns</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swanson</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyer</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drachman</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jhaveri</surname>
                    <given-names>BS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlawish</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pestronk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>TW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tu</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markesbery</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>VE</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations.</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <volume>65</volume>
                <fpage>571</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">16783167</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.guyantmar_chal.2006.644">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guyant-Mar&#x000e9;chal</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laquerri&#x000e8;re</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duyckaerts</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dumanchin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bou</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dugny</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Ber</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fr&#x000e9;bourg</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hannequin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campion</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Valosin-containing protein gene mutations: clinical and neuropathologic features.</article-title>
                <source>Neurology</source>
                <volume>67</volume>
                <fpage>644</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">16790606</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.halawani.2009.4484">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Halawani</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeBlanc</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouiller</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michnick</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Servant</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latterich</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation.</article-title>
                <source>Mol Cell Biol.</source>
                <volume>29</volume>
                <fpage>4484</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">19506019</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.haubenberger.2005.1304">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Haubenberger</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bittner</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauch-Shorny</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mannhalter</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wagner</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mineva</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vass</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auff</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene.</article-title>
                <source>Neurology</source>
                <volume>65</volume>
                <fpage>1304</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16247064</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.hetzer.2001.1086">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hetzer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walther</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bilbao-Cortes</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warren</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mattaj</surname>
                    <given-names>IW</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Distinct AAA-ATPase p97 complexes function in discrete steps of nuclear assembly.</article-title>
                <source>Nat Cell Biol</source>
                <volume>3</volume>
                <fpage>1086</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">11781570</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.hocking.2002.2735">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hocking</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucas</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daroszewska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mangion</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olavesen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cundy</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wuyts</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Hul</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ralston</surname>
                    <given-names>SH</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease.</article-title>
                <source>Hum Mol Genet</source>
                <volume>11</volume>
                <fpage>2735</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12374763</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.h_bbers.2007.381">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>H&#x000fc;bbers</surname>
                    <given-names>CU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clemen</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kesper</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000f6;ddrich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofmann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000e4;m&#x000e4;r&#x000e4;inen</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolksdorf</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stumpf</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichelt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roth</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krause</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wattjes</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reimann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thal</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biermann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evert</surname>
                    <given-names>BO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wanker</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schoser</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noegel</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schr&#x000f6;der</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Pathological consequences of VCP mutations on human striated muscle.</article-title>
                <source>Brain</source>
                <volume>130</volume>
                <fpage>381</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">16984901</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.hutton.1998.702">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hutton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lendon</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Froelich</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Houlden</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pickering-Brown</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakraverty</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isaacs</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grover</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hackett</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adamson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lincoln</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dickson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petersen</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Graaff</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wauters</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Baren</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hillebrand</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joosse</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwon</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nowotny</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Che</surname>
                    <given-names>LK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reed</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trojanowski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Basun</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lannfelt</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neystat</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fahn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dark</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tannenberg</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dodd</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayward</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwok</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schofield</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreadis</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Snowden</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craufurd</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neary</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Owen</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostra</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goate</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Swieten</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mann</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heutink</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.</article-title>
                <source>Nature</source>
                <volume>393</volume>
                <fpage>702</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">9641683</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.jarosch.2002.530">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jarosch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geiss-Friedlander</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meusser</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sommer</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Protein dislocation from the endoplasmic reticulum--pulling out the suspect.</article-title>
                <source>Traffic</source>
                <volume>3</volume>
                <fpage>530</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12121416</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.johnson.2010.857">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandrioli</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benatar</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abramzon</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Deerlin</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trojanowski</surname>
                    <given-names>JQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbs</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunetti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gronka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wuu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ding</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCluskey</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez-Lage</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falcone</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hernandez</surname>
                    <given-names>DG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arepalli</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chong</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schymick</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rothstein</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>YD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mora</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabatelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monsurr&#x000f2;</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battistini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salvi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spataro</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sola</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borghero</surname>
                    <given-names>G</given-names>
                  </name>
                  <collab>ITALSGEN Consortium</collab>
                </person-group>
                <article-title>Galassi G, Scholz SW, Taylor JP, Restagno G, Chi&#x000f2; A, Traynor BJ. Exome sequencing reveals VCP mutations as a cause of familial ALS.</article-title>
                <source>Neuron.</source>
                <year>2010</year>
                <month>Dec</month>
                <day>9</day>
                <volume>68</volume>
                <issue>5</issue>
                <fpage>857</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">21145000</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.ju.2010.r38">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ju</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weihl</surname>
                    <given-names>CC</given-names>
                  </name>
                </person-group>
                <article-title>Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy.</article-title>
                <source>Hum Mol Genet.</source>
                <year>2010</year>
                <volume>19</volume>
                <fpage>R38</fpage>
                <lpage>45</lpage>
                <pub-id pub-id-type="pmid">20410287</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.kimonis.2000.232">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kovach</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waggoner</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salam</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rimer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khardori</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelber</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone.</article-title>
                <source>Genet Med</source>
                <volume>2</volume>
                <fpage>232</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">11252708</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.kimonis.2008.745">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fulchiero</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomasova</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pasquali</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boycott</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neilan</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kartashov</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forman</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tucker</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mumm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whyte</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>GD</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia.</article-title>
                <source>Am J Med Genet</source>
                <volume>146A</volume>
                <fpage>745</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">18260132</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.kondo.1997.75">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rabouille</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pappin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freemont</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warren</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>p47 is a cofactor for p97-mediated membrane fusion.</article-title>
                <source>Nature</source>
                <volume>388</volume>
                <fpage>75</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9214505</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.kovach.2001.458">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kovach</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waggoner</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leal</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelber</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khardori</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levenstien</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanks</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregg</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Lozi</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rakowicz</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopate</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Florence</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Glosser</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simmons</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whyte</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pestronk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>VE</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia.</article-title>
                <source>Mol Genet Metab</source>
                <volume>74</volume>
                <fpage>458</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">11749051</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.kumar.2010.330">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Needham</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mina</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brewer</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staples</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sue</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mastaglia</surname>
                    <given-names>FL</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Two Australian families with inclusion-body myopathy, Paget's disease of bone and frontotemporal dementia: novel clinical and genetic findings.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>20</volume>
                <fpage>330</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20335036</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.laurin.2002.1582">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laurin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morissette</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raymond</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>70</volume>
                <fpage>1582</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11992264</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.lucas.2006.280">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lucas</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hocking</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cundy</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicholson</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walsh</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fraser</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ralston</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>VE</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone.</article-title>
                <source>Bone</source>
                <volume>38</volume>
                <fpage>280</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16199218</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.mcdonald.1995.s117">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McDonald</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abresch</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fowler</surname>
                    <given-names>WM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Kilmer</surname>
                    <given-names>DD</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Profiles of neuromuscular diseases. Limb-girdle syndromes.</article-title>
                <source>Am J Phys Med Rehabil</source>
                <volume>74</volume>
                <fpage>S117</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">7576419</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.mehta.2007.9">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adamson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hutton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Umberger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiong</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramdeen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lovell</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>CD</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD).</article-title>
                <source>Genet Med</source>
                <volume>9</volume>
                <fpage>9</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">17224685</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.mehta.2006.322">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGillivray</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mumm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramdeen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Novack</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Briggs</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whyte</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>VE</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Manifestations in a family with autosomal dominant bone fragility and limb-girdle myopathy.</article-title>
                <source>Am J Med Genet A</source>
                <volume>140</volume>
                <fpage>322</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">16419137</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.meyer.2000.2181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shorter</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seemann</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pappin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warren</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways.</article-title>
                <source>EMBO J</source>
                <volume>19</volume>
                <fpage>2181</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">10811609</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.miller.1997.937">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ikonte</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ponton</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boone</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Darby</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berman</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mena</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cummings</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations.</article-title>
                <source>Neurology</source>
                <volume>48</volume>
                <fpage>937</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">9109881</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.miller.2009.583">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barresi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smart</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eugenicos</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Summers</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clegg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Straub</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stone</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD): clinical features including sphincter disturbance in a large pedigree.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <volume>80</volume>
                <fpage>583</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">19372299</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.neumann.2007.152">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackenzie</surname>
                    <given-names>IR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cairns</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boyer</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markesbery</surname>
                    <given-names>WR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>CD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kretzschmar</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forman</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations.</article-title>
                <source>J Neuropathol Exp Neurol</source>
                <volume>66</volume>
                <fpage>152</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17279000</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.paloneva.2002.656">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Paloneva</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manninen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hovanes</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandelin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adolfsson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianchin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miranda</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salmaggi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tranebjaerg</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Konttinen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peltonen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype.</article-title>
                <source>Am J Hum Genet</source>
                <volume>71</volume>
                <fpage>656</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">12080485</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.rabinovich.2002.626">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rabinovich</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerem</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frohlich</surname>
                    <given-names>KU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diamant</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bar-Nun</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation.</article-title>
                <source>Mol Cell Biol</source>
                <volume>22</volume>
                <fpage>626</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">11756557</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.rabouille.1998.603">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rabouille</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hui</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freemont</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warren</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Syntaxin 5 is a common component of the NSF- and p97-mediated reassembly pathways of Golgi cisternae from mitotic Golgi fragments in vitro.</article-title>
                <source>Cell</source>
                <volume>92</volume>
                <fpage>603</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">9506515</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.ralston.2005.943">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ralston</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galwey</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacKay</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Albagha</surname>
                    <given-names>OM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardon</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Compston</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duncan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langdahl</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLellan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Riordan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pols</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reid</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uitterlinden</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wass</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>ST</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study.</article-title>
                <source>Hum Mol Genet</source>
                <volume>14</volume>
                <fpage>943</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">15746152</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.rape.2001.667">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rape</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoppe</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorr</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalocay</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richly</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jentsch</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mobilization of processed, membrane-tethered SPT23 transcription factor by CDC48(UFD1/NPL4), a ubiquitin-selective chaperone.</article-title>
                <source>Cell</source>
                <volume>107</volume>
                <fpage>667</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">11733065</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.schr_der.2005.457">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schr&#x000f6;der</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evert</surname>
                    <given-names>BO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broich</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fliessbach</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pauls</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hans</surname>
                    <given-names>VH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thal</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mutant valosin-containing protein causes a novel type of frontotemporal dementia.</article-title>
                <source>Ann Neurol</source>
                <volume>57</volume>
                <fpage>457</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">15732117</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.van_der_zee.2009.626">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Zee</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pirici</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Langenhove</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelborghs</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vandenberghe</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pusswald</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van den Broeck</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peeters</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mattheijssens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Deyn</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruts</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haubenberger</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar-Singh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimprich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His.</article-title>
                <source>Neurology.</source>
                <volume>73</volume>
                <fpage>626</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">19704082</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.waggoner.2002.187">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Waggoner</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kovach</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Winkelman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cai</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khardori</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelber</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>VE</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Heterogeneity in familial dominant Paget disease of bone and muscular dystrophy.</article-title>
                <source>Am J Med Genet</source>
                <volume>108</volume>
                <fpage>187</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">11891683</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.watts.2005.508">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramdeen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Novack</surname>
                    <given-names>DV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mumm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whyte</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mc Gillivray</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>VE</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mapping autosomal dominant progressive limb-girdle myopathy with bone fragility to chromosome 9p21-p22: a novel locus for a musculoskeletal syndrome.</article-title>
                <source>Hum Genet</source>
                <volume>118</volume>
                <fpage>508</fpage>
                <lpage>14</lpage>
                <pub-id pub-id-type="pmid">16244874</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.watts.2007.420">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Watts</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomasova</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramdeen</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fulchiero</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehta</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drachman</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weihl</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jamrozik</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kwiecinski</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaminska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kimonis</surname>
                    <given-names>VE</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia.</article-title>
                <source>Clin Genet</source>
                <volume>72</volume>
                <fpage>420</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17935506</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.wilhelmsen.1996.507">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilhelmsen</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blake</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mabutas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vera</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neystat</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilliam</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sola</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schotland</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hays</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rowland</surname>
                    <given-names>LP</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Chromosome 12-linked autosomal dominant scapuloperoneal muscular dystrophy.</article-title>
                <source>Ann Neurol</source>
                <volume>39</volume>
                <fpage>507</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">8619529</pub-id>
              </element-citation>
            </ref>
            <ref id="ibmpfd.REF.zhang.2000.1473">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bates</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gowen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orlova</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorman</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dokurno</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lally</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meyer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Heel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Freemont</surname>
                    <given-names>PS</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Structure of the AAA ATPase p97.</article-title>
                <source>Mol Cell</source>
                <volume>6</volume>
                <fpage>1473</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">11163219</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="ibmpfd.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="ibmpfd.Author_Notes">
          <title>Author Notes</title>
          <p>Dr Kimonis&#x02019; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.faculty.uci.edu/profile.cfm?faculty_id=5799&#x00026;name=Virginia%20E%20Kimonis">University of California, Irvine profile</ext-link></p>
        </sec>
        <sec id="ibmpfd.Acknowledgments">
          <title>Acknowledgments</title>
          <p>We acknowledge the support of the NIH MDA and the contribution of collaborators and families. Funding of this study is from the NINDS, NIAMS, National Institutes of Health (RO1, R03 AR 46869), Muscular Dystrophy Association, and Paget Foundation.</p>
        </sec>
        <sec id="ibmpfd.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>28 July 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 May 2009 (cd) Revision: prenatal testing available clinically</p>
            </list-item>
            <list-item>
              <p>5 March 2008 (cd) Revision: sequence analysis available clinically</p>
            </list-item>
            <list-item>
              <p>25 May 2007 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>18 November 2004 (vk, gw) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="ibmpfd.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>IBMPFD phenotypes</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ibmpfd-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
